Investing.com -- Agios Pharmaceuticals announced that the U.S. Food and Drug Administration has approved mitapivat for treating anemia in adults with alpha- or beta-thalassemia. The treatment will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback